menu
    • menu

    Company profile for Akouos

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Akouos is a genetic medicines company dedicated to developing gene therapies with the potential to restore, improve or preserve hearing. Leveraging its adeno-associated viral (AAV) vector-based gene therapy platform, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. The company’s first gene therapy development program, AK-OTOF, is for individuals with sensorineural hearing loss due ...
    Akouos is a genetic medicines company dedicated to developing gene therapies with the potential to restore, improve or preserve hearing. Leveraging its adeno-associated viral (AAV) vector-based gene therapy platform, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. The company’s first gene therapy development program, AK-OTOF, is for individuals with sensorineural hearing loss due to mutations in the otoferlin (OTOF) gene. Akouos has strategic partnerships with Massachusetts Eye and Ear and Lonza, Inc.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AkouosUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Akouos, Inc. 645 Summer Street Suite 200 Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eyes, Ears Get Their Due With Cell and Gene Therapy
    Eyes, Ears Get Their Due With Cell and Gene Therapy

    03 Sep 2024

    // BIOSPACE

    https://www.biospace.com/drug-development/eyes-ears-get-their-due-with-cell-and-gene-therapy

    BIOSPACE
    03 Sep 2024
    Share Share
    Lilly and Akouos Announce Expiration of Akouos Tender Offer
    Lilly and Akouos Announce Expiration of Akouos Tender Offer

    30 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-and-akouos-announce-expiration-of-akouos-tender-offer-301690086.html

    PRNEWSWIRE
    30 Nov 2022
    Share Share
    Akouos Reports 3Q 2022 Financial Results & Provides Business Highlights
    Akouos Reports 3Q 2022 Financial Results & Provides Business Highlights

    14 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/14/2554841/0/en/Akouos-Reports-Third-Quarter-2022-Financial-Results-and-Provides-Business-Highlights.html

    GLOBENEWSWIRE
    14 Nov 2022
    Share Share
    String of gene therapy deals spurs cautious optimism on Wall Street
    String of gene therapy deals spurs cautious optimism on Wall Street

    01 Nov 2022

    // Jacob Bell BIOPHARMADIVE

    https://www.biopharmadive.com/news/gene-therapy-deals-acquisitions-akouos-agtc-taysha/635523/

    Jacob Bell BIOPHARMADIVE
    01 Nov 2022
    Share Share
    Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout
    Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout

    19 Oct 2022

    // Tristan Manalac BIOSPACE

    https://www.biospace.com/article/lilly-continues-foray-into-gene-therapies-with-487m-akouos-buyout/

    Tristan Manalac BIOSPACE
    19 Oct 2022
    Share Share
    Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
    Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss

    18 Oct 2022

    // PRESS RELEASE

    https://investors.akouos.com/news-releases/news-release-details/lilly-acquire-akouos-discover-and-develop-treatments-hearing

    PRESS RELEASE
    18 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search